SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid discussions about the government shutdown, potential $2000 dividend payments, and the recent local elections. Community members are debating the impact of Trump's policies, particularly tariffs and healthcare, with some expressing concern over potential market manipulation. There's also active discussion around the company's financial performance.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending amid news of its acquisition of AI infrastructure company Northern Data and advertising commitments from Tether. The community is discussing the potential impact of this acquisition, particularly regarding Rumble's cloud capabilities and Tether's increased ownership stake. Many believe the deal positions Rumble to better compete in the cloud and AI space, while others are focused on the stock's high short interest and potential for a squeeze.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group (UNH) is trending amid discussions around potential government policy changes affecting healthcare, including the ACA subsidies, with some fearing negative impacts while others anticipate long-term gains due to the company's diversified portfolio and potential for growth in a changing landscape. Community perspectives are split, with some expressing concern over short-term volatility and policy impacts, while others view the pullback as a buying opportunity, citing strong fundamentals, potential for a rebound, and confidence in long-term growth.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending as community members discuss its potential in the AI sector and its recent performance. Some are attributing the increased activity to NEAR's growing number of active users, while others speculate about future price targets. The conversation also includes mentions of staking and integrations with other projects like Sweatcoin.

Listed Funds Trust - Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF ($XXRP) is trending as traders discuss its potential for amplified gains relative to XRP, with some citing upcoming catalysts like spot ETF approvals and regulatory clarity. Community members are actively trading the ETF, sharing strategies and discussing entry/exit points amid volatile swings. Some traders are also comparing $XXRP to other similar assets, such as $XRPT, and discussing which may be a better investment.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors await the European Medicines Agency's (EMA) decision on Blarcamesine for Alzheimer's, with the community closely watching for the agenda release. Discussions revolve around the potential for approval given numerically superior clinical efficacy and safety, with community members also pointing to key opinion leaders in Europe supporting the drug. Some are drawing comparisons to other Alzheimer's plays while others are anticipating a short squeeze if the agency approves the treatment.

SSgA Active Trust - Health Care Select Sector SPDR

Health Care Select Sector SPDR Fund

The healthcare sector, represented by XLV, is gaining attention as discussions revolve around its potential breakout and long-term value. Community members are weighing potential factors such as sector rotation, oversold conditions, and technical patterns. Additionally, legislative and earnings catalysts may influence the sector's movement.

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium ($CCD) is trending as the community highlights its focus on compliance-ready infrastructure, privacy-preserving technology, and real-world utility within the PayFi ecosystem. Recent partnerships, including integrations with Ledger and bitcoin.com/, are driving increased attention and bullish sentiment, positioning Concordium as a standout Layer-1 blockchain for enterprise adoption and regulated DeFi.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BBAI is trending as investors brace for upcoming earnings, with opinions split on whether the company can deliver. The reopening of the government is also a key focus, with many anticipating new contract announcements. The community is actively debating potential price movements and long-term prospects amidst broader market volatility affecting AI stocks.

Newsmax Inc. is a holding company, which engages in television broadcasting and multi-platform content publishing that produces original news and editorial content for consumers through various media outlets, including TV new channels, digital and print publications. It operates through the Broadcasting and Digital Segments. The Broadcasting segment produces and licenses news, business news and lifestyle content for distribution through both MVPDs and free OTT streaming platforms. The Digital segment is composed of Newsmax.com and affiliated websites. The company was founded by Christopher Ruddy in 1998 and is headquartered in Boca Raton, FL.

Newsmax Inc. - Ordinary Shares - Class B

Newsmax Inc

Newsmax ($NMAX) is trending as discussions revolve around potential market manipulation and trading strategies, as well as political commentary. Community members are debating the stock's volatility, potential for a short squeeze, and its alignment with political figures. The broader discussion involves market dynamics and political views.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Morgan Stanley, Evercore ISI, and Barclays raised price targets to between $28–$32, citing Omada’s revenue growth and its first positive adjusted EBITDA.</li><li>The company plans to integrate GLP-1 prescribing and medication management into its weight-health program, expanding its digital-care platform.</li><li>Retail traders highlighted the company’s strong balance sheet, high gross margins, and operating leverage as signs of growth potential.</li></ul><p>Retail chatter on Omada Health surged over the weekend after several brokerages raised price targets following stronger-than-expected third-quarter (Q3) results and the company’s new GLP-1 prescribing initiative for its weight-health program.</p><h2 class="st-heading-2"><strong>Analyst Upgrades</strong></h2><p>Morgan Stanley raised its price target on Omada Health to $32 from $30 and kept an ‘Overweight’ rating, citing 49% year-over-year revenue growth, an 11% beat versus consensus, and the company’s first quarter of positive adjusted EBITDA. The firm said momentum continues and highlighted the addition of GLP-1 prescribing to Omada’s offering as a key development.</p><p>Evercore ISI increased its price target to $28 from $27 and maintained an ‘Outperform’ rating, noting that Q3 revenue and EBITDA beat expectations and full-year 2025 guidance was raised.</p><p>Barclays lifted its price target to $29 from $28 and reiterated an ‘Overweight’ rating, describing Omada’s results as “another beat and raise quarter.”</p><h2 class="st-heading-2"><strong>Q3 Review</strong></h2><p>Omada reported revenue of $68 million, ahead of consensus estimates of $61.2 million. Total members rose 53% to 831,000, while the company’s net loss narrowed to $3 million from $9 million a year earlier. Omada achieved its first positive adjusted EBITDA of $2 million, compared with a $5 million loss in the prior-year period.</p><p>Gross margin improved to 66%, and cash and cash equivalents totaled $199 million at quarter-end.</p><p>CEO Sean Duffy said the results demonstrate “the strength of Omada’s multi-product platform” as the company deepens its innovation in GLP-1 care options and AI tools aimed at delivering “sustainable outcomes” and “cost savings” for customers.</p><h2 class="st-heading-2"><strong>GLP-1 Expansion And Product Updates</strong></h2><p>The company announced plans to integrate prescribing and medication management for anti-obesity medications, including GLP-1s, into its weight-health program.</p><p>Omada also launched Meal Map, an AI-driven nutrition platform that prioritizes nutrient quality over calorie tracking, and published results from its 30th peer-reviewed research study, which showed savings generated from its Joint &amp; Muscle Health program. Additional results showed that members largely sustained their weight a year after stopping GLP-1 treatment.</p><h2 class="st-heading-2"><strong>Financial Outlook</strong></h2><p>Omada raised its FY25 revenue guidance to $251.5 million-$254.5 million, up from a prior range of $235 million–$241 million, and now expects adjusted EBITDA between breakeven and a $2 million loss, compared with earlier guidance for a $9 million–$5 million loss.</p><h2 class="st-heading-2"><strong>Stocktwits Traders Say Omada’s GLP-1 Plan Shows Real Execution</strong></h2><p>On Stocktwits, retail sentiment for Omada was ‘extremely bullish’ amid ‘extremely high’ message volume.</p><figure class="image"><img style="aspect-ratio:963/138;" src="https://news.stocktwits-cdn.com/omda_ss_jpg_d120b63835.webp" alt="omda ss.jpg" width="963" height="138"><figcaption>OMDA sentiment and message volume as of November 9 | Source: Stocktwits</figcaption></figure><p>One user said some companies “just mention GLP-1 to garner headlines” without clear execution plans, but noted that Omada Health already has case studies, proof-of-concept, and “the balance sheet to boost this up.” They added that the business model is proven and now depends on strong marketing to capture the opportunity.</p><p><stembedurl>https://stocktwits.com/Jasooon/message/635551904</stembedurl></p><p>Another user said the company’s financials “prove it,” pointing to high gross margins, positive adjusted EBITDA, and improved cash flow as signs of operating leverage and a “stellar management team.”</p><p><stembedurl>https://stocktwits.com/Jasooon/message/635551456</stembedurl></p><p><a href="https://stocktwits.com/symbol/OMDA">Omada Health’s stock</a> has declined 12% so far in 2025.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the Omada Health logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Omada Health Stock Jumps Into Retail Focus As Wall Street Lifts Price Targets After ‘Beat And Raise’ Quarter, GLP-1 Push

Morgan Stanley, Evercore ISI, and Barclays raised price targets to between $28–$32, citing Omada’s revenue growth and its first positive adjusted EBITDA.

Equity

Teacher Retirement System of Texas Acquires New Stake in Omada Health, Inc. $OMDA

Teacher Retirement System of Texas bought a new position in Omada Health, Inc. (NASDAQ:OMDA - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities...

Omada Health (NASDAQ:OMDA) Price Target Raised to $29.00

Barclays increased their target price on shares of Omada Health from $28.00 to $29.00 and gave the stock an "overweight" rating in a research report on Friday...

Omada Health (NASDAQ:OMDA) Trading Down 11.1% - Time to Sell?

Omada Health (NASDAQ:OMDA) Trading Down 11.1% - Here's Why...

Omada Health (NASDAQ:OMDA) Price Target Raised to $28.00

Evercore ISI increased their target price on Omada Health from $27.00 to $28.00 and gave the stock an "outperform" rating in a research report on Friday...

Needham & Company LLC Issues Positive Forecast for Omada Health (NASDAQ:OMDA) Stock Price

Needham & Company LLC increased their price objective on shares of Omada Health from $26.00 to $28.00 and gave the stock a "buy" rating in a research note on Friday...

Omada Health (NASDAQ:OMDA) Releases Quarterly Earnings Results, Beats Estimates By $0.21 EPS

Omada Health (NASDAQ:OMDA - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.21...

Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics

The headline numbers for Omada Health, Inc. (OMDA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows

The announcement expands the offerings under the company's weight management program as its membership grows to more than 100,000...

15 names that Morgan Stanley’s analysts expect to move meaningfully on earnings

Investing.com -- Morgan Stanley expects a “normal” earnings beat rate for the second quarter, with S&P 500 EPS growth forecast at 5% year-over-year and sales up 4%.

Omada Health, Inc. engages in the provision of digital health services. It offers online diabetes and obesity prevention programs, health coaching, and integration of web, mobile, and smart devices. The company was founded by Andrew DiMichele, Adrian James, and Sean Duffy on April 25, 2011 and is headquartered in South San Francisco, CA.

Omada Health Inc.

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$21.31
Prev Close	$21.87
Open	$22.75
Dividend Yield	N/A
50-Day Moving Average	$23.70
Beta	-0.15
Avg. Volume	330,965.74
PE Ratio	-35.28

52-Week High	$28.40
52-Week Low	$14.14
Market Capitalization	$1.17B
EPS (Annual)	-$0.8456
Price to Book	5.43
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

OMDA
Omada Health, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OMDA News

OMDAOmada Health, Inc.